Paper28480899
Immunosuppressive cell death in cancer.
Hou J and 2 others. Nat Rev Immunol, 2017. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Immunosuppressive cell death in cancer. Papers, record 28480899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28480899
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Communicable Diseases | Major topic |
| Neoplasms | Major topic |
| Cell Death | |
| Humans | |
| Immunosuppressive Agents |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z99 CA999999 | Intramural NIH HHS | United States | Z99CA999999 | PubMed | NIH RePORTER |
| ZIABC011343 | NIH | NIH RePORTER |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 28480896 | Reply: Immunosuppressive cell death in cancer. | https://conductscience.org/library/papers/28480896 | PubMed |
| Comment on | 27748397 | Immunogenic cell death in cancer and infectious disease. | https://conductscience.org/library/papers/27748397 | PubMed |
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24746841 | MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. | Lancet Oncol | 2014 | https://conductscience.org/library/papers/24746841 | PubMed |
| 2 | 26343536 | CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation. | Nat Immunol | 2015 | https://conductscience.org/library/papers/26343536 | PubMed |
| 3 | 25681553 | Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. | J Hepatol | 2015 | https://conductscience.org/library/papers/25681553 | PubMed |
| 4 | 27828943 | Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells. | Nature | 2016 | https://conductscience.org/library/papers/27828943 | PubMed |
| 5 | 25822788 | IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. | Nature | 2015 | https://conductscience.org/library/papers/25822788 | PubMed |
| 6 | 27434011 | Interleukin 1α and the inflammatory process. | Nat Immunol | 2016 | https://conductscience.org/library/papers/27434011 | PubMed |
| 7 | 21992733 | The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. | Future Oncol | 2011 | https://conductscience.org/library/papers/21992733 | PubMed |
| 8 | 27748397 | Immunogenic cell death in cancer and infectious disease. | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/27748397 | PubMed |
| 9 | 22770218 | A CXCL1 paracrine network links cancer chemoresistance and metastasis. | Cell | 2012 | https://conductscience.org/library/papers/22770218 | PubMed |
| 10 | 27049944 | The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. | Nature | 2016 | https://conductscience.org/library/papers/27049944 | PubMed |
| 11 | 25344738 | Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. | Nat Med | 2014 | https://conductscience.org/library/papers/25344738 | PubMed |
| 12 | 17128264 | Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. | Nat Cell Biol | 2006 | https://conductscience.org/library/papers/17128264 | PubMed |
| 13 | 23723299 | HMGB1 in cancer: good, bad, or both? | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23723299 | PubMed |
| 14 | 27626381 | Ionic immune suppression within the tumour microenvironment limits T cell effector function. | Nature | 2016 | https://conductscience.org/library/papers/27626381 | PubMed |
| 15 | 25924065 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. | Nature | 2015 | https://conductscience.org/library/papers/25924065 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42165001 | Sequential nanocatalytic therapy and lysosomal dysfunction for overcoming castration-resistant prostate cancer. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42165001 | PubMed |
| 42036664 | Evolving antibody-drug conjugates in breast cancer from precision delivery to tumor microenvironment reprogramming. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42036664 | PubMed |
| 40502358 | Plasma IFN-γ may predict pyrotinib efficacy in patients with HER2-positive advanced breast cancer. | Biomed Rep | 2025 | https://conductscience.org/library/papers/40502358 | PubMed |
| 39817135 | Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature. | World J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/39817135 | PubMed |
| 39766152 | H1 Antihistamines-Promising Candidates for Repurposing in the Context of the Development of New Therapeutic Approaches to Cancer Treatment. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39766152 | PubMed |
| 38825147 | EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms. | Prostaglandins Other Lipid Mediat | 2024 | https://conductscience.org/library/papers/38825147 | PubMed |
| 37276392 | Tumor cell-derived spermidine is an oncometabolite that suppresses TCR clustering for intratumoral CD8+ T cell activation. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37276392 | PubMed |
| 36746936 | Regulation of immunological tolerance by the p53-inhibitor iASPP. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/36746936 | PubMed |
| 36707233 | Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. | Gut | 2023 | https://conductscience.org/library/papers/36707233 | PubMed |
| 35675434 | Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35675434 | PubMed |
| 35440553 | Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations. | Nat Commun | 2022 | https://conductscience.org/library/papers/35440553 | PubMed |
| 32228703 | Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32228703 | PubMed |
| 31868112 | Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy. | Nanomedicine (Lond) | 2020 | https://conductscience.org/library/papers/31868112 | PubMed |
| 31315034 | Inflammation and Cancer: Triggers, Mechanisms, and Consequences. | Immunity | 2019 | https://conductscience.org/library/papers/31315034 | PubMed |
| 29484440 | Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review). | Int J Oncol | 2018 | https://conductscience.org/library/papers/29484440 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL1 | 2919 | PubTator's text mining | https://conductscience.org/library/genes/2919 | NCBI Gene |
| CXCL10 | 3627 | PubTator's text mining | https://conductscience.org/library/genes/3627 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| ITGAM | 3684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
| NOLC1 | 9221 | PubTator's text mining | https://conductscience.org/library/genes/9221 | NCBI Gene |
| S100A1 | 6271 | PubTator's text mining | https://conductscience.org/library/genes/6271 | NCBI Gene |
| SAP130 | 79595 | PubTator's text mining | https://conductscience.org/library/genes/79595 | NCBI Gene |
| SIN3A | 25942 | PubTator's text mining | https://conductscience.org/library/genes/25942 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28480899
GET https://conductscience.org/api/papers/v1/28480899/authors